Healthtech funding in H1 2019
European Healthtech startup funding raised during H1 2019.
In H1 2019, 220 European Healthtech companies closed 220 funding rounds and raised €2.1B in equity funding (excluding debt and grants), up 37.1% versus H1 2018. France led by capital raised, and aMoon Fund was the most active investor. Data as of 20 Nov 2026.
Equity funding
€2.1B
+37.1% vs H1 2018 · excl. debt & grants
Funding rounds
220
+14.0% vs H1 2018
Companies
220
Top country
France
Rank among sectors
#3
7.8% of sector funding
Top-10 round share
29.7%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H1 2019 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €1.3B | 115 |
| Apr | €811M | 104 |
| Jun | €15M | 1 |
Top countries
by € raisedHealthtech — top countries by capital, H1 2019 — interactive chart.
Data table
| Healthtech — top countries by capital, H1 2019 | |
|---|---|
| France | €473M |
| Israel | €369M |
| UK | €237M |
| Switzerland | €179M |
| Belgium | €156M |
| Ireland | €127M |
| Netherlands | €91M |
| Poland | €90M |
Stage mix
by € raisedHealthtech — stage mix, H1 2019 — interactive chart.
Data table
| Healthtech — stage mix, H1 2019 | |
|---|---|
| Series B | €533M |
| Other | €520M |
| Series A | €485M |
| Series D+ | €371M |
| Series C | €120M |
| Seed | €71M |
| Growth/Late | €15M |
| Pre-Seed | €596k |
Exits & M&A
14 Acquisition · 2 IPO16 exits · €563M disclosed.
| InMode | IPO | Feb 2019 | €384M |
| Nutrino | Acquisition | Jan 2019 | €91M |
| EXIMO MEDICAL | Acquisition | Apr 2019 | €40M |
| Sequana Medical | IPO | Jan 2019 | €28M |
| Bokadirekt | Acquisition | Jan 2019 | €21M |
Top deals
largest disclosed rounds in H1 2019| Company | Stage | Date | Amount |
|---|---|---|---|
| Doctolib | Series D+ | Jan 2019 | €150M |
| docplanner | Series D+ | Apr 2019 | €80M |
| Sophia Genetics | Series D+ | Jan 2019 | €67M |
| Bioserenity | Series B | Apr 2019 | €65M |
| Inivata | Series B | Jan 2019 | €46M |
| DentalMonitoring | Other | Jan 2019 | €45M |
| Vivet Therapeutics | Other | Jan 2019 | €45M |
| Alvotech | Other | Jan 2019 | €44M |
| Syqe Medical | Other | Jan 2019 | €44M |
| Snipr Biome | Series A | Jan 2019 | €44M |
| Promethera Biosciences | Series D+ | Apr 2019 | €40M |
| Atai Life Sciences | Series B | Jan 2019 | €38M |
| Imcyse | Series B | Apr 2019 | €35M |
| DNA Script | Series B | Apr 2019 | €34M |
| EarlySense | Series D+ | Jan 2019 | €34M |
Top investors
most active in H1 2019, by deal count- aMoon Fund3 deals
- Balderton Capital3 deals
- Bpifrance3 deals
- High-Tech Gründerfonds (HTGF)3 deals
- Horizon 20203 deals
- Innovate UK3 deals
- 24Haymarket2 deals
- btov Partners2 deals
- Capital Cell2 deals
- Elaia2 deals